Trial Outcomes & Findings for (CONCERN) Clinical Decision Support (CDS) System (NCT NCT03911687)

NCT ID: NCT03911687

Last Updated: 2025-05-09

Results Overview

Number of patient deaths occurring in the hospital.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

60893 participants

Primary outcome timeframe

Up to 24 months

Results posted on

2025-05-09

Participant Flow

Clusters were the individual clinical units across the four hospitals that included all non-specialty acute care units (ACUs) and intensive care units (ICUs).

Unit of analysis: clinical unit

Participant milestones

Participant milestones
Measure
Control Group
Control data will be collected in the CONCERN CDS system that will be "live" in the EHR, but in silent release mode (e.g., not providing notification to clinicians).
Intervention Group
Experimental data will be collected in the CONCERN CDS system that will be "live" in the EHR in "active" release mode (e.g., providing CONCERN CDS system notification to clinicians).
Overall Study
STARTED
27869 37
33024 37
Overall Study
COMPLETED
27869 37
33024 37
Overall Study
NOT COMPLETED
0 0
0 0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

(CONCERN) Clinical Decision Support (CDS) System

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Control Group
n=27 Participants
Control data will be collected in the CONCERN CDS system that will be "live" in the EHR, but in silent release mode (e.g., not providing notification to clinicians).
Intervention Group
n=33 Participants
Experimental data will be collected in the CONCERN CDS system that will be "live" in the EHR in "active" release mode (e.g., providing CONCERN CDS system notification to clinicians).
Total
n=60893 Participants
Total of all reporting groups
Age, Continuous
63.67 years
STANDARD_DEVIATION 17.10 • n=5 Participants
62.62 years
STANDARD_DEVIATION 17.56 • n=7 Participants
63.1 years
STANDARD_DEVIATION 17.4 • n=5 Participants
Sex: Female, Male
Female
13,903 Participants
n=5 Participants
16,968 Participants
n=7 Participants
30871 Participants
n=5 Participants
Sex: Female, Male
Male
13,966 Participants
n=5 Participants
16,056 Participants
n=7 Participants
30022 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
5,903 Participants
n=5 Participants
7,442 Participants
n=7 Participants
13345 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
20,304 Participants
n=5 Participants
23,618 Participants
n=7 Participants
43922 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1,662 Participants
n=5 Participants
1,964 Participants
n=7 Participants
3626 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
634 Participants
n=5 Participants
703 Participants
n=7 Participants
1337 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
4,224 Participants
n=5 Participants
4,878 Participants
n=7 Participants
9102 Participants
n=5 Participants
Race (NIH/OMB)
White
16,278 Participants
n=5 Participants
18,923 Participants
n=7 Participants
35201 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
6,733 Participants
n=5 Participants
8,520 Participants
n=7 Participants
15253 Participants
n=5 Participants
Region of Enrollment
United States
27,869 participants
n=5 Participants
33,024 participants
n=7 Participants
60893 participants
n=5 Participants
Primary language English
22,584 Participants
n=5 Participants
26,713 Participants
n=7 Participants
49297 Participants
n=5 Participants
Clinical unit type
ACU
25,704 Participants
n=5 Participants
31,050 Participants
n=7 Participants
56754 Participants
n=5 Participants
Clinical unit type
ICU
2,165 Participants
n=5 Participants
1,974 Participants
n=7 Participants
4139 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Up to 24 months

Number of patient deaths occurring in the hospital.

Outcome measures

Outcome measures
Measure
CONCERN Intervention Group
n=33 Participants
Experimental data will be collected in the CONCERN CDS system that will be "live" in the EHR in "active" release mode (e.g., providing CONCERN CDS system notification to clinicians).
Usual Care Group
n=27 Participants
Control data will be collected in the CONCERN CDS system that will be "live" in the EHR, but in silent release mode (e.g., not providing notification to clinicians).
In-hospital Mortalities
181 Participants
265 Participants

PRIMARY outcome

Timeframe: Up to 24 months

The number of days that a patient was in the hospital

Outcome measures

Outcome measures
Measure
CONCERN Intervention Group
n=33 Participants
Experimental data will be collected in the CONCERN CDS system that will be "live" in the EHR in "active" release mode (e.g., providing CONCERN CDS system notification to clinicians).
Usual Care Group
n=27 Participants
Control data will be collected in the CONCERN CDS system that will be "live" in the EHR, but in silent release mode (e.g., not providing notification to clinicians).
Average Length of Hospital Stay
6.6 days
Standard Deviation 0.82
7.2 days
Standard Deviation 0.9

SECONDARY outcome

Timeframe: Up to 24 months

Cardiopulmonary events during hospitalization

Outcome measures

Outcome measures
Measure
CONCERN Intervention Group
n=33 Participants
Experimental data will be collected in the CONCERN CDS system that will be "live" in the EHR in "active" release mode (e.g., providing CONCERN CDS system notification to clinicians).
Usual Care Group
n=27 Participants
Control data will be collected in the CONCERN CDS system that will be "live" in the EHR, but in silent release mode (e.g., not providing notification to clinicians).
Number of Cardiac Arrests
123 Participants
128 Participants

SECONDARY outcome

Timeframe: Up to 24 months

Sepsis occurring during hospitalization

Outcome measures

Outcome measures
Measure
CONCERN Intervention Group
n=33 Participants
Experimental data will be collected in the CONCERN CDS system that will be "live" in the EHR in "active" release mode (e.g., providing CONCERN CDS system notification to clinicians).
Usual Care Group
n=27 Participants
Control data will be collected in the CONCERN CDS system that will be "live" in the EHR, but in silent release mode (e.g., not providing notification to clinicians).
Number of Hospital Acquired Sepsis
1,461 Participants
1,578 Participants

SECONDARY outcome

Timeframe: Up to 24 months

Transfer to ICU from acute care study units during hospitalization

Outcome measures

Outcome measures
Measure
CONCERN Intervention Group
n=33 Participants
Experimental data will be collected in the CONCERN CDS system that will be "live" in the EHR in "active" release mode (e.g., providing CONCERN CDS system notification to clinicians).
Usual Care Group
n=27 Participants
Control data will be collected in the CONCERN CDS system that will be "live" in the EHR, but in silent release mode (e.g., not providing notification to clinicians).
Number of Unanticipated Transfers to ICU
505 Participants
377 Participants

SECONDARY outcome

Timeframe: Up to 24 months

Readmission to the hospital within 30 days of being discharged alive.

Outcome measures

Outcome measures
Measure
CONCERN Intervention Group
n=33 Participants
Experimental data will be collected in the CONCERN CDS system that will be "live" in the EHR in "active" release mode (e.g., providing CONCERN CDS system notification to clinicians).
Usual Care Group
n=27 Participants
Control data will be collected in the CONCERN CDS system that will be "live" in the EHR, but in silent release mode (e.g., not providing notification to clinicians).
Number of Hospital Readmissions
2,544 Participants
2,234 Participants

Adverse Events

CONCERN Intervention Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 181 deaths

Usual Care Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 265 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Sarah Collins Rossetti, PhD

Columbia University

Phone: 2123056605

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place